FrancophonIA/ELRC3.0 huggingface dataset:
English: Questions and answers on the recommendation to lift the suspension of Octagam (human normal immunoglobulin 5% and 10%)
Slovenian: Vprašanja in odgovori v zvezi s priporočilom za preklic začasnega umika dovoljenj za promet z zdravilom Octagam (humani normalni imunoglobulin 5 % in 10 %)
English: Questions and answers on the recommendation to lift the suspension of Octagam (human normal immunoglobulin 5% and 10%) EMA/293780/2011 rev.
Slovenian: Vprašanja in odgovori v zvezi s priporočilom za preklic začasnega umika dovoljenj za promet z zdravilom Octagam (humani normalni imunoglobulin 5 % in 10 %) EMA/567271/2011 rev.
English: The European Medicines Agency has completed a review of Octagam and associated names that was triggered by reports of serious thromboembolic events in patients using the medicine.
Slovenian: Evropska agencija za zdravila je zaključila pregled zdravila Octagam in povezanih imen, ki so ga sprožila poročila o hudih tromboemboličnih dogodkih pri bolnikih, ki so jemali zdravilo.
English: The Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended that the EU-wide suspension of the marketing authorisation for Octagam be lifted subject to certain conditions, including a change to the medicine's manufacturing process.
Slovenian: Odbor za zdravila za uporabo v humani medicini (CHMP) pri Agenciji je priporočil, da se začasni umik dovoljenj za promet z zdravilom Octagam po vsej EU prekliče pod določenimi pogoji, vključno s spremembo postopka proizvodnje zdravila.
English: The CHMP also agreed on a test to detect factor XIa or other substances that can cause thromboembolic events before batches are released onto the market.
Slovenian: CHMP se je strinjal tudi s preverjanjem prisotnosti faktorja XIa ali drugih snovi, ki bi lahko povzročile tromboembolične dogodke, pred sproščanjem serij na tržišče.
English: In September 2010, the CHMP, following the suspension of the marketing authorisations of Octagam in Germany and Sweden, recommended that all authorisations for the medicine be suspended across the EU.
Slovenian: CHMP je septembra 2010 po začasnem umiku dovoljenj za promet z zdravilom Octagam v Nemčiji in na Švedskem priporočil, da se začasno umaknejo vsa dovoljenja za promet z zdravilom Octagam v EU.
English: The marketing authorisation holders will also be required to carry out post-marketing safety studies as soon as the medicine is reintroduced into the market in order to confirm the safety of the improved manufacturing process.
Slovenian: Ko bo zdravilo znova na tržišču, bodo imetniki dovoljenj za promet z zdravilom morali izvesti tudi varnostne študije v obdobju trženja in tako potrditi varnost izboljšanega proizvodnega postopka.
English: These events were thought to be related to problems with the medicine's manufacture, and included stroke, myocardial infarction (heart attack) and pulmonary embolism (clot in a blood vessel supplying the lungs).
Slovenian: Med dogodki, ki naj bi bili povezani s težavami pri proizvodnji zdravila, so bili kap, miokardni infarkt (srčni napad) in pljučna embolija (strdek v žili, ki dovaja kri v pljuča).
English: Why was Octagam reviewed?
Slovenian: Zakaj je bilo zdravilo Octagam pregledano?
English: Another enzyme, kallikrein, is considered to play a minor role.
Slovenian: Manjši vpliv naj bi imel tudi drug encim, imenovan kalikrein.
English: The marketing authorisations for Octagam in the EU were suspended by the European Commission, following a review by the CHMP in the September 2010.
Slovenian: Evropska komisija je dovoljenja za promet z zdravilom Octagam po vsej EU začasno umaknila po pregledu CHMP septembra 2010.1
English: Octagam is a solution for infusion (drip into a vein) that contains human normal immunoglobulin extracted from blood as the active substance.
Slovenian: Zdravilo Octagam je raztopina za infundiranje (kapalna infuzija v veno), ki vsebuje zdravilno učinkovino humani normalni imunoglobulin, pridobljen iz krvi.
English: The CHMP concluded the review with a recommendation that the suspension of the marketing authorisation for Octagam be lifted in the EU on the basis of the safeguards and the change to the medicine's manufacturing process.
Slovenian: CHMP je pregled sklenil s priporočilom, da se na podlagi ustreznih zaščitnih ukrepov in sprememb v postopku proizvodnje zdravila začasni umik dovoljenj za promet z zdravilom Octagam v EU prekliče.
English: The background to the suspension was an unexpectedly high number of reports of serious thromboembolic events (problems due to the formation of blood clots in the blood vessels) in patients
Slovenian: Dovoljenja za promet z zdravilom so začasno umaknili po nepričakovano visokem številu poročil o hudih tromboemboličnih dogodkih (težave zaradi nastajanja krvnih strdkov v žilah) pri bolnikih, ki so jemali zdravilo.
English: The CHMP concluded that the unexpected presence of factor XIa (an enzyme involved in blood clotting) in Octagam was the main cause of the thromboembolic events.
Slovenian: CHMP je sklenil, da je glavni vzrok tromboemboličnih dogodkov nepričakovana prisotnost faktorja XIa (encima, ki sodeluje pri strjevanju krvi) v zdravilu Octagam.
English: Contains aspartame.
Slovenian: Vsebuje aspartam.
English: Tell your doctor.
Slovenian: Povejte svojemu zdravniku.
English: Interaction studies have only been performed in adults.
Slovenian: Študije interakcij so izvajali samo pri odraslih.
English: This will usually pass on its own but if it does not, tell your doctor.
Slovenian: To običajno mine samo od sebe, če pa ne, povejte svojemu zdravniku.
English: Gröbenzell, Germany
Slovenian: Gröbenzell, Nemčija
English: City Tower, Hvězdova 1716/2b, 140 78 Praha 4 Czech Republic
Slovenian: City Tower, Hvězdova 1716/2b, 140 78 Praha 4, Češka
English: Tell your doctor if you are taking, have recently taken or might take any other medicines.
Slovenian: Obvestite svojega zdravnika, če jemljete ali ste pred kratkim jemali ali pa boste morda začeli jemati katerokoli drugo zdravilo.
English: Hertfordshire, WD18 8YA, United Kingdom
Slovenian: Hertfordshire, WD18 8YA, Velika Britanija
English: In particular, tell your doctor if you are taking:
Slovenian: Še zlasti pa povejte svojemu zdravniku, če jemljete:
English: If you are pregnant or breast-feeding, think you might be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine.
Slovenian: Če ste noseči ali dojite, menite, da bi lahko bili noseči ali načrtujete zanositev, se posvetujte s svojim zdravnikom, preden vzamete to zdravilo.
English: This leaflet was last revised in {MM/YYYY}.
Slovenian: Navodilo je bilo nazadnje revidirano v {mesec LLLL}
English: Your doctor will tell you how many Olanzapine Glenmark tablets to take and how long you should continue to take them.
Slovenian: Zdravnik vam bo povedal, koliko Olanzapine Glenmark tablet morate vzeti in kako dolgo naj bi jih jemali.
English: - if you have been previously diagnosed with eye problems such as certain kinds of glaucoma (increased pressure in the eye).
Slovenian: - če so vam v preteklosti ugotovili težave z očmi kot je določena vrsta glavkoma (povišan tlak v očesu).
English: - Medicines of this type may cause unusual movements mainly of the face or tongue.
Slovenian: • Tovrstna zdravila lahko povzročijo nenavadne zgibke predvsem v mišicah obraza ali jezika.
English: However, olanzapine (5-20 mg) demonstrated a comparable safety profile in female (n = 467) as in male patients (n = 869).
Slovenian: Vendar pa je olanzapin (520 mg) pokazal primerljiv profil varnosti tako pri bolnikih ženskega (n = 467) kot moškega spola (n = 869).
English: In adult patients who completed 9-12 months of therapy, the rate of increase in mean blood glucose slowed after approximately 6 months.
Slovenian: Pri odraslih bolnikih, ki so zaključili 9-12 mesecev terapije, se je razmerje zvišanja povprečne glukoze v krvi upočasnilo po približno 6 mesecih.
English: If this has happened to you, tell your doctor.
Slovenian: Če se vam je zgodilo kaj takega, povejte svojemu zdravniku.
English: As a routine precaution, if you are over 65 years your blood pressure may be monitored by your doctor.
Slovenian: Kot običajen previdnostni ukrep vam lahko vaš zdravnik nadzoruje krvni tlak, če ste stari več kot 65 let.
English: If you suffer from dementia, you or your carer/relative should tell your doctor if you have ever had a stroke or “mini” stroke.
Slovenian: Če ste bolnik z demenco, morate vi ali vaš skrbnik/sorodnik povedati vašemu zdravniku, če ste kdaj doživeli možgansko kap ali »majhno« možgansko kap.
English: 31, D - 82194 Gröbenzell, Germany
Slovenian: 31, D - 82194 Gröbenzell, Nemčija
English: Do not take Olanzapine Glenmark - if you are allergic (hypersensitive) to olanzapine or any of the other ingredients of this medicine (listed in section 6).
Slovenian: Ne jemljite zdravila Olanzapine Glenmark: - če ste alergični na (preobčutljivi za) olanzapin ali katerokoli sestavino tega zdravila (navedeno v poglavju 6).
English: • In the early stages of treatment, some people may feel dizzy or faint (with a slow heart rate), especially when getting up from a lying or sitting position.
Slovenian: Nekateri ljudje imajo lahko v začetnih obdobjih zdravljenja občutek omotice ali oslabelosti (z upočasnjenim srčnim utripom), zlasti pri vstajanju iz ležečega ali sedečega položaja.
English: Children and adolescents Olanzapine Glenmark is not for patients who are under 18 years.
Slovenian: Otroci in mladostniki Zdravilo Olanzapine Glenmark ni namenjeno bolnikom, mlajšim od 18 let.
English: Your doctor should do blood tests to check blood sugar and certain fat levels before you start taking Olanzapine Glenmark and regularly during treatment.
Slovenian: Vaš zdravnik mora opraviti krvni test za preiskavo sladkorja v krvi in nivo določenih maščob pred začetkom jemanja zdravila OLANZAPINE in redno tekom zdravljenja.
English: In clinical studies, the average olanzapine exposure was approximately 27 % higher in adolescents.
Slovenian: V kliničnih študijah je bila povprečna izpostavitev približno 27 % višja pri mladostnikih.
English: In patients with Parkinson's disease Olanzapine Glenmark may worsen the symptoms.
Slovenian: Pri bolnikih s Parkinsonovo boleznijo lahko zdravilo Olanzapine Glenmark poslabša simptome.
English: Activated charcoal reduces the bioavailability of oral olanzapine by 50 to 60 % and should be taken at least 2 hours before or after olanzapine.
Slovenian: Aktivno oglje zmanjša biološko uporabnost peroralnega olanzapina za 50 do 60 % in ga je treba zaužiti vsaj 2 uri pred olanzapinom ali vsaj dve uri po njem.
English: All olanzapine and placebo-treated patients who experienced a cerebrovascular event had pre-existing risk factors.
Slovenian: Vsi bolniki, ki so prejemali olanzapin ali placebo in so doživeli cerebrovaskularni dogodek, so imeli prej obstoječe dejavnike tveganja.
English: You should not be given this medicine when breast-feeding, as small amounts of Olanzapine Glenmark can pass into breast milk.
Slovenian: Ko dojite, tega zdravila ne smete jemati, ker lahko majhne količine zdravila Olanzapine Glenmark prehajajo v materino mleko.
English: 1 Clinically significant weight gain was observed across all baseline Body Mass Index (BMI)
Slovenian: 1Klinično značilno zvečanje telesne mase so opažali preko celotne osnove kategorij Indeksa telesne mase (BMI, Body Mass Index).
English: The mean increase in olanzapine Cmax following fluvoxamine was 54 % in female non smokers and 77 % in male smokers.
Slovenian: Srednje zvišanje Cmax olanzapina po dajanju fluvoksamina je bilo 54 % pri ženskah nekadilkah in 77 % pri moških kadilcih.
English: In a study in breast- feeding, healthy women, olanzapine was excreted in breast milk.
Slovenian: V študiji pri doječih zdravih ženskah se je olanzapin izločal v materino mleko.
English: If you forget to take Olanzapine Glenmark Take your tablets as soon as you remember.
Slovenian: Če ste pozabili vzeti zdravilo Olanzapine Glenmark Vzemite tablete, kakor hitro se spomnite.
English: During treatment for schizophrenia, manic episode and recurrence prevention in bipolar disorder, daily dosage may subsequently be adjusted on the basis of individual clinical status within the range 520 mg/day.
Slovenian: Med zdravljenjem shizofrenije, manične epizode in preprečevanjem ponovnega pojava bipolarne motnje se lahko dnevni odmerek na podlagi individualnega kliničnega stanja kasneje prilagodi v razponu 5 do 20 mg na dan.
English: If you suffer from any of the following illnesses tell your doctor as soon as possible:
Slovenian: Če imate katero od spodaj naštetih bolezni, čimprej povejte svojemu zdravniku:
English: • Carbamazepine (an anti-epileptic and mood stabiliser), fluvoxamine (an antidepresant) or ciprofloxacin (an antibiotic) - it may be necessary to change your Olanzapine Glenmark dose.
Slovenian: • karbamazepin (antiepileptik in stabilizator razpoloženja), fluvoksamin (antidepresiv) ali ciprofloksacin (antibiotik) - morda bo treba spremeniti vaš odmerek zdravila Olanzapine Glenmark.
English: • Moderate to severe manic episodes, a condition with symptoms of excitement or euphoria.
Slovenian: • zmernih do resnejših maničnih epizod, bolezni s simptomi razburjenja ali evforije
English: Very common: Decreased total bilirubin, increased GGT, elevated plasma prolactin levels 16
Slovenian: Zelo pogosti: Nizek celokupni bilirubin, visok GGT, zvišane plazemske koncentracije prolaktina16
English: You should take your Olanzapine Glenmark tablets once a day following the advice of your doctor.
Slovenian: Olanzapine Glenmark tablete jemljite enkrat na dan, in sicer upoštevajte nasvet zdravnika.
English: It is important that you carry on taking Olanzapine Glenmark for as long as your doctor tells you.
Slovenian: Pomembno je, da nadaljujete z jemanjem zdravila Olanzapine Glenmark tako dolgo, kot vam naroči zdravnik.
English: Discontinuation symptoms7, 12
Slovenian: dtegnitveni simptomi7, 12
English: - Tell your doctor if you or someone else in your family has a history of blood clots, as medicines like these have been associated with the formation of blood clots.
Slovenian: • Če ste vi ali kdo iz vaše družine v preteklosti imeli krvne strdke, morate o tem obvestiti svojega zdravnika, saj lahko zdravila, kot je to, povzročijo nastanek krvnih strdkov.
English: Long-term olanzapine treatment (up to 12 months) for recurrence prevention in patients with bipolar disorder was associated with an increase of ≥ 7 % from baseline body weight in 39.9 % of patients.
Slovenian: Dolgoročno zdravljenje z olanzapinom (do 12 mesecev) za preprečevanje ponovnega pojava bolezni pri bolnikih z bipolarno motnjo je bilo povezano s povečanjem telesne mase za ≥ 7 % z osnove pri 39,9 % bolnikov.
English: The plasma protein binding of Olanzapine was about 93 % over the concentration range of about 7 to about 1000 ng/ml.
Slovenian: Vezava olanzapina na plazemske beljakovine je bila okoli 93 % v razponu koncentracij od približno 7 do približno 1000 ng/ml.
English: However the risk of tardive dyskinesia increases with long-term exposure, and therefore if signs or symptoms of tardive dyskinesia appear in a patient on olanzapine, a dose reduction or discontinuation should be considered.
Slovenian: Vendar pa tveganje za tardivne diskinezije narašča s trajanjem zdravljenja in je zato ob pojavu znakov ali simptomov tardivnih diskinezij pri bolniku, ki prejema olanzapin, treba razmisliti o znižanju odmerka ali ukinitvi zdravila.
English: Effects on haematology parameters were found in each species, including dose-related reductions in circulating leukocytes in mice and non-specific reductions of circulating leukocytes in rats; however, no evidence of bone marrow cytotoxicity was found.
Slovenian: Pri vsaki vrsti so odkrili učinke na hematološke parametre, vključno z odmerkom povezanimi znižanji koncentracij levkocitov v obtoku pri miših in nespecifičnim znižanjem koncentracije levkocitov v obtoku pri podganah; vendar pa niso našli dokazov citotoksičnosti za kostni mozeg.
English: If this happens, contact your doctor at once.
Slovenian: Če se zgodi kaj takega, se nemudoma obrnite na svojega zdravnika.
English: Consult your doctor if your symptoms return but do not stop taking Olanzapine Glenmark unless your doctor tells you to.
Slovenian: Če se simptomi povrnejo, se posvetujte s svojim zdravnikom, vendar ne prenehajte jemati zdravila Olanzapine Glenmark, če vam tega ne naroči vaš zdravnik.
English: What Olanzapine Glenmark is and what it is used for What you need to know before you take Olanzapine Glenmark How to take Olanzapine Glenmark Possible side effects
Slovenian: Kaj je zdravilo Olanzapin Glenmark in za kaj ga uporabljamo Kaj morate vedeti, preden boste vzeli zdravilo Olanzapin Glenmark Kako jemati zdravilo Olanzapin Glenmark Možni neželeni učinki
English: DRESS appears initially as flu-like symptoms with a rash on the face and then with an extended rash, high temperature, enlarged lymph nodes, increased levels of liver enzymes seen in blood tests and an increase in a type of white blood cell (eosinophilia).
Slovenian: Sindrom DRESS se sprva kaže kot gripi podobni simptomi z izpuščajem na obrazu, nato pa z razširjenim izpuščajem, visoko telesno temperaturo, povečanimi bezgavkami, povišanimi ravnmi jetrnih encimov na izvidih krvnih testov in s povišanjem vrste belih krvničk (eozinofilija).
English: Olanzapine Glenmark 2.5 mg tablets Olanzapine Glenmark 5 mg tablets Olanzapine Glenmark 7.5 mg tablets Olanzapine Glenmark 10 mg tablets Olanzapine Glenmark 15 mg tablets Olanzapine Glenmark 20 mg tablets
Slovenian: Olanzapin Glenmark 2,5 mg tablete Olanzapin Glenmark 5 mg tablete Olanzapin Glenmark 7,5 mg tablete Olanzapin Glenmark 10 mg tablete Olanzapin Glenmark 15 mg tablete Olanzapin Glenmark 20 mg tablete olanzapin
English: The frequency terms listed are defined as follows: Very common (≥ 1/10), common (≥ 1/100 to <
Slovenian: Našteti izrazi pogostnosti so definirani kot sledi: zelo pogosti (≥ 1/10), pogosti (≥ 1/100 do < 1/10).
English: The frequency terms listed are defined as follows: Very common (≥ 1/10), common (≥ 1/100 to < 1/10), uncommon (≥ 1/1,000 to < 1/100), rare (≥ 1/10,000 to < 1/1,000), very rare (< 1/10,000), not known (cannot be estimated from the data available).
Slovenian: Našteti izrazi pogostnosti so definirani kot sledi: zelo pogosti (≥ 1/10), pogosti (≥ 1/100 do < 1/10), občasni (≥ 1/1.000 do < 1/100), redki (≥ 1/10.000 do < 1/1.000), zelo redki (< 1/10.000), ni znano (ocena ni možna iz danih podatkov).
English: Pancreatitis11
Slovenian: Pankreatitis11
English: Cytochromes P450-CYP1A2 and P450-CYP2D6 contribute to the formation of the N-desmethyl and 2-hydroxymethyl metabolites, both exhibited significantly less in vivo pharmacological activity than olanzapine in animal studies.
Slovenian: Citokroma P450-CYP1A2 in P450CYP2D6 prispevata k tvorbi N-demetilnih in 2-hidroksimetilnih metabolitov, oboji so v študijah na živalih pokazali pomembno manj farmakološke aktivnosti in vivo kot olanzapin.
English: Date of latest renewal: 19 August 2014
Slovenian: Datum zadnjega podaljšanja dovoljenja za promet: 19 Avgust 2014
English: Olanzapine is bound predominantly to albumin and α1-acid-glycoprotein.
Slovenian: Olanzapin se veže predvsem na albumin in 1-kisli glikoprotein.
English: Do not use this medicine after the expiry date which is stated on the carton and blister after EXP.
Slovenian: Tega zdravila ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na škatli in pretisnem omotu poleg oznake »Uporabno do«.
English: Olanzapine should be used cautiously in patients who have a history of seizures or are subject to factors, which may lower the seizure threshold.
Slovenian: Olanzapin je treba uporabljati previdno pri bolnikih, ki so imeli v preteklosti epileptične napade ali so podvrženi dejavnikom, ki bi lahko znižali prag za epileptične napade.
English: DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 03 December 2009
Slovenian: DATUM PRIDOBITVE/PODALJŠANJA DOVOLJENJA ZA PROMET Datum pridobitve dovoljenja za promet: 03 December 2009
English: In addition, a Single Photon Emission Computed Tomography (SPECT) imaging study in schizophrenic patients revealed that olanzapine-responsive patients had lower striatal D2 occupancy than some other antipsychotic and risperidone-responsive patients, while being comparable to clozapine-responsive patients.
Slovenian: Dodatno je SPECT (Single Photon Emission Computed Tomography) slikovna študija pri bolnikih s shizofrenijo razkrila, da so imeli bolniki, ki so se odzivali na olanzapin, nižjo zasedenost striatnih D2 receptorjev kot bolniki, ki so se odzivali na nekatere druge antipsihotike in risperidon, medtem ko je bila primerljiva z bolniki, ki so se odzivali na klozapin.
English: This may be harmful for people with phenylketonuria.
Slovenian: Lahko škoduje ljudem s fenilketonurijo.
English: 2 Mean increases in fasting lipid values (total cholesterol, LDL cholesterol, and triglycerides) were greater in patients without evidence of lipid dysregulation at baseline.
Slovenian: 2Povprečna povišanja vrednosti lipidov na tešče (celokupni holesterol, LDL holesterol in trigliceridi) so bila večja pri bolnikih brez očitne slabe regulacije lipidov na osnovi.
English: The most frequently (seen in ≥ 1 % of patients) reported adverse reactions associated with the use of olanzapine in clinical trials were somnolence, weight gain, eosinophilia, elevated prolactin, cholesterol, glucose and triglyceride levels (see section 4.4), glucosuria, increased appetite, dizziness, akathisia, parkinsonism, leukopenia, neutropenia (see section 4.4), dyskinesia, orthostatic hypotension, anticholinergic effects, transient asymptomatic elevations of hepatic aminotransferases (see section 4.4), rash, asthenia, fatigue, pyrexia, arthralgia, increased alkaline phosphatase, high gamma glutamyltransferase, high uric acid, high creatine phosphokinase and oedema.
Slovenian: Najpogosteje poročani (opažene pri  1 % bolnikov) neželeni učinki, povezani z uporabo olanzapina v kliničnih preskušanjih, so bili zaspanost, povečanje telesne mase, eozinofilija, zvišane ravni prolaktina, holesterola, glukoze in trigliceridov (glejte poglavje 4.4), glikozurija, povečan apetit, omotica, akatizija, parkinsonizem, levkopenija, nevtropenija (glejte poglavje 4.4), diskinezija, ortostatska hipotenzija, antiholinergični učinki, prehodna asimptomatska zvišanja jetrnih aminotransferaz (glejte poglavje 4.4), izpuščaj, astenija, utrujenost, pireksija, artralgija, zvišana alkalna fosfataza, visoka raven gama-glutamiltransferaze, visoka raven sečne kisline, visoka raven kreatin-fosfokinaze in edem.
English: The daily dose of Olanzapine Glenmark is between 5 mg and 20 mg.
Slovenian: Dnevni odmerek zdravila Olanzapine Glenmark je med 5 mg in 20 mg.
English: Olanzapine Glenmark tablets are for oral use.
Slovenian: Olanzapine Glenmark obložene tablete so za peroralno uporabo.
English: Olanzapine administered with lithium or valproate resulted in increased levels (≥ 10 %) of tremor, dry mouth, increased appetite, and weight gain.
Slovenian: Olanzapin dan z litijem ali valproatom je povzročil zvišane ravni (≥ 10 %) tresenja, suhih ust, povečanega apetita in povečanja telesne mase.
English: If you take more Olanzapine Glenmark than you should Patients who have taken more Olanzapine Glenmark than they should have experienced the following symptoms: rapid beating of the heart, agitation/aggressiveness, problems with speech, unusual movements (especially of the face or tongue) and reduced level of consciousness.
Slovenian: Če ste vzeli večji odmerek zdravila Olanzapine Glenmark, kot bi smeli Bolniki, ki so vzeli večji odmerek zdravila Olanzapine Glenmark, kot bi smeli, so imeli naslednje simptome: hitro bitje srca, vznemirjenost/nasilnost, težave pri govoru, nenavadne zgibke (posebno v mišicah obraza ali jezika) in zmanjšano stopnjo zavesti.
English: Olanzapine Glenmark tablet contains aspartame, which is a source of phenylalanine.
Slovenian: Zdravilo Olanzapin Glenmark tablete vsebuje aspartam, ki je vir fenilalanina.
English: 6.4 Special precautions for storage Store below 30C
Slovenian: 6.4 Posebna navodila za shranjevanje Shranjujte pri temperaturi do 30 C.
English: Store below 30C.
Slovenian: Shranjujte pri temperaturi do 30 C.